Autophagic- and Lysosomal-Related Biomarkers for Parkinson’s Disease: Lights and Shadows
Parkinson’s disease (PD) is a neurodegenerative disorder that currently affects 1% of the population over the age of 60 years, for which no disease-modifying treatments exist. This lack of effective treatments is related to the advanced stage of neurodegeneration existing at the time of di...
المؤلفون الرئيسيون: | Helena Xicoy, Núria Peñuelas, Miquel Vila, Ariadna Laguna |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
MDPI AG
2019-10-01
|
سلاسل: | Cells |
الموضوعات: | |
الوصول للمادة أونلاين: | https://www.mdpi.com/2073-4409/8/11/1317 |
مواد مشابهة
-
Novel autophagy inducers by accelerating lysosomal clustering against Parkinson’s disease
حسب: Yuki Date, وآخرون
منشور في: (2024-06-01) -
The Emerging Role of the Lysosome in Parkinson’s Disease
حسب: Alba Navarro-Romero, وآخرون
منشور في: (2020-11-01) -
The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
حسب: Eddie Pradas, وآخرون
منشور في: (2023-01-01) -
Autophagic dysregulation triggers innate immune activation in glucocerebrosidase deficiency
حسب: Magda L. Atilano, وآخرون
منشور في: (2024-12-01) -
Crosstalk between Lysosomes and Mitochondria in Parkinson's Disease
حسب: Nicoletta Plotegher, وآخرون
منشور في: (2017-12-01)